KennethRHallowsMDPhD, FASN

Professor of Medicine; Chief, Division of Nephrology and Hypertension; Director, USC/UKRO Kidney Research Center / University of Southern California Keck School of Medicine

Join to view full profile

Dr. Hallows is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hallows' full profile

Already have an account?

Office
2020 Zonal Ave
# IRD806
Los Angeles, CA 90089
Phone+1 323-442-1040

Fax+1 323-442-2881

Education & Training

University of Pennsylvania Health SystemFellowship, Nephrology, 1997 - 2001
University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1997
University of Rochester School of Medicine and DentistryClass of 1995
Brown UniversitySc.B., Biophysics, Magna cum Laude, 1983 - 1987

Certifications & Licensure

CA State Medical License 2015 - 2027
PA State Medical License 1996 - 2016
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (ASNF) American Society of Nephrology

Clinical Trials

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2016 Jun 27
Completed
Phase 2

Publications & Presentations

PubMed

4 citations
Female Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity.
Hak Joo Lee, Liang Min, Jingli Gao, Shane Matta, Viktor Drel
Diabetes. 2024-07-01
5 citations
Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.
Biao Huang, Zipeng Zeng, Sunghyun Kim, Connor C Fausto, Kari Koppitch
Cell Stem Cell. 2024-06-06
1 citations
Investigation of Basolateral Targeting Micelles for Drug Delivery Applications in Polycystic Kidney Disease.
Yi Huang, Ali Osouli, Jessica Pham, Valeria Mancino, Colette O'Grady
Biomacromolecules. 2024-05-13

Journal Articles

Design and in vivo characterization of kidney-targeting peptide amphiphile micelles toward renal drug delivery
Wang, J., Poon, C., Chin, D., Milkowski, S., Lu, V., Hallows, K.R., and Chung, E.J., Nano Res. 11(10): 5584-5595, 2018.
Muc1 is protective during kidney ischemia-reperfusion injury
Pastor-Soler, N.M., Sutton, T.A., Mang, H.E., Kinlough, C.L., Gendler, S.J., Madsen, C.S., Bastacky, S., Ho, J., Al-bataineh, M.M., Hallows, K.R., Singh, S., Monga, S...., Am. J. Physiol. Renal Physiol.

Lectures

Metabolic Reprogramming in Polycystic Kidney Disease
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney InjurySeptember 2018

Press Mentions

World Kidney Day: Keck Medicine of USC Experts Discuss Kidney Health and ResearchMarch 8th, 2017
MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney InjurySeptember 19th, 2018

Grant Support

Effects of Combination Therapy with Tolvapatan and the Farnesoid X Receptor Agonist INT-747 on Hepatotoxicity, Metabolic and Injury Biomarkers, and Cystogenesis in ADPKDOtsuka Pharmaceuticals, Inc.2019–2020
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (Clinical Trial Award)U.S. Department of Defense2015–2020
Cellular Energy Pathways as Novel Targets for the Therapy of Autosomal Dominant Polycystic Kidney DiseaseU.S. Department of Defense2015–2018
Mechanisms and Relevance of Sodium Transport Regulation by AMPKNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2012–2017
Mechanisms And Relevance Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Mechanisms Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2001
Novel Interaction Of Amp-Kinase With CFTR C1 ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases2000
Novel Interaction Of Amp-Kinase With CFTR CL ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases1999